ILMN Illumina, Inc. - Common Stock
$200,06
Kurs · Aug 19, 2026
Fundamentaldaten per Jul 31, 2026
52W-Spanne
$88–$207
94% of range
Analystenbewertung
BUY
28 analysts
Kursziel
$199
P/E (TTM)
48.2
ROE
34.1%
Nettogewinnmarge
19.6%
Über Illumina, Inc. - Common Stock Unternehmensübersicht von Wikipedia
Illumina ist ein US-amerikanischer Hersteller von Geräten für die Gentechnik mit Sitz in San Diego. Das Unternehmen wurde 1998 gegründet und ging im Jahr 2000 an die Börse. llumina besitzt einen Marktanteil von 71 % bei Sequenzierautomaten. Die Sequenzierer detektieren, wie die Sanger-Sequenzierung, mittels sequencing-by-synthesis (SBS).
Mehr lesen
Illumina ist ein US-amerikanischer Hersteller von Geräten für die Gentechnik mit Sitz in San Diego. Das Unternehmen wurde 1998 gegründet und ging im Jahr 2000 an die Börse. llumina besitzt einen Marktanteil von 71 % bei Sequenzierautomaten. Die Sequenzierer detektieren, wie die Sanger-Sequenzierung, mittels sequencing-by-synthesis (SBS).
## Geschichte
Von 1999 bis Ende 2016 wurde Illumina von Jay Flatley geleitet, welcher nach seinem Abgang als CEO noch bis 2021 als Executive Chairman arbeitete.
2007 übernahm Illumina die Firma Solexa. Bei Solexa wurde die Solexa/Illumina DNA-Sequenzierungsmethode entwickelt (von David Klenerman und Shankar Balasubramanian, die 1998 Solexa gründeten). 2006 übernahm Illumina Solexa für 600 Millionen Dollar.
Im September 2022 hat die EU-Kommission die Übernahme des Krebstestentwicklers Grail durch Illumina verboten, um den Wettbewerb zwischen den Entwicklern von Krebsfrüherkennungstests zu bewahren. Dies nachdem die Übernahme im August 2021 bereits vollzogen worden war. Grail war 2016 von Illumina gegründet worden, die mit 14,6 % der größte Aktionär des Unternehmens blieb. Zu den Mitbesitzern gehörten Jeff Bezos und Bill Gates.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
ILMN Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$200.06
Marktkapitalisierung
$40.21B
P/E (TTM)
48.2
EPS (TTM)
$5.45
Umsatz (TTM)
$4.34B
Dividendenrendite
—
ROE
34.1%
Verschuldungsgrad
0.2
52W-Spanne
$88 – $207
ILMN Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$4.34B
2017-01-01
→
2025-12-28
EPS
$5.45
2017-01-01
→
2025-12-28
Freier Cashflow
$931M
2017-01-01
→
2025-12-28
Margen
19.6%
2017-01-01
→
2025-12-28
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ILMN
Peer-Median
P/E (TTM)
48.2
39.9
P/S (TTM) (K/V (TTM))
9.3
5.6
P/B (K/B)
14.8
4.1
Price / FCF (Kurs / FCF)
43.2
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ILMN
Peer-Median
Gross Margin (Bruttogewinnmarge)
66.1%
46.4%
Operating Margin (Betriebsgewinnmarge)
18.6%
—
Net Profit Margin (Nettogewinnmarge)
19.6%
11.7%
ROA
13.1%
4.7%
ROE
34.1%
8.5%
ROIC
19.6%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ILMN
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
0.2
15.3
Current Ratio (Liquiditätsgrad)
2.1
1.7
Quick Ratio
0.7
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ILMN
Peer-Median
Revenue YoY (Umsatz YoY)
-0.66%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-1.8%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
6.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ILMN
Peer-Median
ILMN Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
28 Analysten
- Starker Kauf 7 25,0%
- Kauf 10 35,7%
- Halten 8 28,6%
- Verkauf 2 7,1%
- Starker Verkauf 1 3,6%
12-Monats-Kursziel
19 Analysten · 2026-08-17
Median
$211.00
Mittelwert
$198.89
Jetzt
$200.06
Tief
$113.00
Hoch
$230.00
Median-Ziel
$211.00
+5,5%
Mittelwert-Ziel
$198.89
-0,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.09%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $1.31 | $1.25 | 0.06% |
| 31. März 2026 | $1.15 | $1.08 | 0.07% |
| 31. Dezember 2025 | $1.15 | $1.08 | 0.07% |
| 30. September 2025 | $1.34 | $1.19 | 0.15% |
| 30. Juni 2025 | $1.19 | $1.03 | 0.16% |
| 31. März 2025 | $0.97 | $0.96 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ILMN | $20.65B | 24.8 | -0.66% | 19.6% | 34.1% | 66.1% |
| TMO | $257.86B | 32.7 | 3.9% | 15.0% | 13.0% | — |
| DHR | $161.82B | 45.3 | 2.9% | 14.7% | 7.1% | 59.1% |
| A | $41.43B | 32.0 | 6.7% | 18.8% | 20.6% | — |
| IQV | $38.23B | 28.8 | 5.9% | 8.3% | 21.6% | — |
| WAT | $22.62B | 35.3 | 7.0% | 20.3% | 27.2% | — |
| MTD | $28.38B | 33.2 | 4.0% | 21.6% | -615.5% | 59.4% |
| WST | $19.81B | 40.5 | 6.2% | 16.1% | 16.2% | 35.9% |
| MEDP | $15.93B | 36.8 | 20.0% | 17.8% | 142.9% | — |
| TEM | — | -41.9 | 83.4% | -19.3% | -61.2% | — |
| CRL | $10.02B | -70.0 | -0.85% | -3.6% | -4.4% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B | $2.22B | $1.86B | |
| Cost of Revenue | $1.47B | $1.51B | $1.76B | $1.61B | $1.37B | $1.04B | $1.08B | $1.03B | $926M | $732M | $671M | $564M | |
| Gross Profit | $2.87B | $2.86B | $2.74B | $2.97B | $3.15B | $2.20B | $2.47B | $2.30B | $1.83B | $1.67B | $1.55B | $1.30B | |
| R&D Expense | $967M | $1.17B | $1.35B | $1.32B | $1.19B | $682M | $647M | $623M | $546M | $504M | $401M | $388M | |
| SG&A Expense | $1.09B | $1.09B | $1.61B | $1.30B | $2.09B | $941M | $835M | $794M | $674M | $584M | $516M | $466M | |
| Operating Expenses | $2.06B | $3.69B | $3.81B | $7.15B | $3.28B | $1.62B | $1.48B | $1.42B | $1.22B | $1.08B | $936M | $783M | |
| Operating Income | $807M | $-833M | $-1.07B | $-4.18B | $-123M | $580M | $985M | $883M | $606M | $587M | $613M | $515M | |
| Interest Expense | · | · | $77M | $26M | $61M | $49M | $52M | $57M | $37M | $33M | $43M | $42M | |
| Interest Income | $40M | $46M | $58M | $11M | $0 | $41M | $75M | $44M | $19M | $10M | $5M | $4M | |
| Other Non-op | $340M | $-292M | $-29M | $-142M | $1.07B | $284M | $110M | $24M | $455M | $-3M | $-8M | $-33M | |
| Pretax Income | $1.09B | $-1.18B | $-1.12B | $-4.34B | $884M | $856M | $1.12B | $894M | $1.04B | $561M | $583M | $449M | |
| Income Tax | $236M | $44M | $44M | $68M | $122M | $200M | $128M | $112M | $365M | $133M | $125M | $95M | |
| Net Income | $850M | $-1.22B | $-1.16B | $-4.40B | $762M | $656M | $1.00B | $826M | $726M | $463M | $462M | $353M | |
| EPS (Basic) | $5.47 | $-7.69 | $-7.34 | $-28.00 | $5.07 | $4.48 | $6.81 | $5.63 | $4.96 | $3.09 | $3.19 | $2.61 | |
| EPS (Diluted) | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 | $4.45 | $6.74 | $5.56 | $4.92 | $3.07 | $3.10 | $2.37 | |
| Shares (Basic) | 155,000,000 | 159,000,000 | 158,000,000 | 157,000,000 | 150,000,000 | 147,000,000 | 147,000,000 | 147,000,000 | 146,000,000 | 147,000,000 | 145,000,000 | 135,553,000 | |
| Shares (Diluted) | 156,000,000 | 159,000,000 | 158,000,000 | 157,000,000 | 151,000,000 | 148,000,000 | 149,000,000 | 149,000,000 | 148,000,000 | 148,000,000 | 149,000,000 | 148,977,000 | |
| EBITDA | $1.08B | $-479M | $-637M | $-3.79B | $128M | $767M | $1.17B | $1.06B | $762M | $729M | $613M | · |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | $1.14B | $1.23B | $735M | $769M | $636M | |
| Short-term Investments | $215M | $93M | $6M | $26M | $107M | $1.66B | $1.37B | $2.37B | $920M | $824M | $617M | $702M | |
| Receivables | $854M | $735M | $734M | $671M | $648M | $487M | $573M | $514M | $411M | $381M | $386M | $289M | |
| Inventory | $564M | $547M | $587M | $568M | $431M | $372M | $359M | $386M | $333M | $300M | $271M | $191M | |
| Prepaid Expense | $238M | $244M | $234M | $285M | $295M | $152M | $105M | $78M | $91M | $78M | $54M | $30M | |
| Current Assets | $3.29B | $2.75B | $2.61B | $3.56B | $2.71B | $4.48B | $4.45B | $4.49B | $2.98B | $2.32B | $2.10B | $1.89B | |
| PP&E (Net) | $759M | $815M | $1.01B | $1.09B | $1.02B | $922M | $889M | $1.07B | $931M | $713M | $343M | $265M | |
| PP&E (Gross) | $2.12B | $2.07B | $2.15B | $2.05B | $1.82B | $1.60B | $1.46B | $1.60B | $1.35B | $1.04B | $609M | $480M | |
| Accum. Depreciation | $1.36B | $1.25B | $1.14B | $962M | $796M | $678M | $568M | $521M | $416M | $327M | $267M | $215M | |
| Goodwill | $1.11B | $1.11B | $2.54B | $3.24B | $7.11B | $897M | $897M | $831M | $771M | $776M | $753M | $725M | |
| Intangibles | $210M | $295M | $2.99B | $3.29B | $3.25B | $142M | $145M | $185M | $175M | $243M | $274M | $314M | |
| Other Non-current Assets | $449M | $348M | $357M | $423M | $445M | $609M | $388M | $308M | $312M | $108M | $87M | $96M | |
| Total Assets | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B | $3.69B | $3.34B | |
| Accounts Payable | $240M | $221M | $245M | $293M | $332M | $192M | $149M | $184M | $160M | $138M | $139M | $83M | |
| Accrued Liabilities | $846M | $827M | $1.32B | $1.23B | $761M | $541M | $516M | $513M | $432M | $342M | $387M | $335M | |
| Short-term Debt | $499M | $499M | $0 | $500M | $0 | · | · | · | · | · | · | · | |
| Current Liabilities | $1.58B | $1.55B | $1.57B | $2.77B | $1.09B | $1.24B | $665M | $1.80B | $746M | $705M | $610M | $722M | |
| Capital Leases | $486M | $554M | $687M | $744M | $774M | $671M | $695M | · | · | · | · | · | |
| Other Non-current Liabilities | $360M | $339M | $620M | $649M | $915M | $303M | $202M | $359M | $360M | $206M | $181M | $168M | |
| Long-term Debt | · | · | · | · | · | $1.18B | $1.14B | $2.00B | $1.19B | $1.06B | $1.09B | $1.29B | |
| Total Debt | $499M | $499M | $0 | $500M | · | $1.18B | $1.14B | $2.00B | $1.19B | $1.05B | $1.09B | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Paid-in Capital | $7.82B | $7.53B | $9.55B | $9.21B | $8.94B | $3.81B | $3.56B | $3.29B | $2.83B | $2.73B | $2.50B | $2.17B | |
| Retained Earnings | $-392M | $-1.24B | $-19M | $1.14B | $5.49B | $4.72B | $4.07B | $3.08B | $2.26B | $1.49B | $1.02B | $561M | |
| Treasury Stock | $4.70B | $3.93B | $3.79B | $3.75B | $3.70B | $3.85B | $3.02B | $2.62B | $2.34B | $2.02B | $1.67B | $1.27B | |
| AOCI | $-10M | $22M | $-1M | $3M | $17M | $2M | $5M | $-1M | $-1M | $-1M | $36.0K | $-1M | |
| Stockholders' Equity | $2.72B | $2.37B | $5.75B | $6.60B | $10.74B | $4.69B | $4.61B | $3.85B | $2.75B | $2.20B | $1.85B | $1.46B | |
| Liabilities + Equity | $6.64B | $6.30B | $10.11B | $12.25B | $15.22B | $7.58B | $7.32B | $6.96B | $5.26B | $4.28B | $3.69B | $3.34B | |
| Shares Outstanding | 201,000,000 | 200,000,000 | 199,000,000 | 198,000,000 | 197,000,000 | 195,000,000 | 147,000,000 | 147,000,000 | 147,000,000 | 146,000,000 | 146,584,000 | 143,629,000 |
Cashflow 19
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $270M | $354M | $432M | $394M | $251M | $187M | $188M | $179M | $156M | $141M | $127M | $113M | |
| Stock-based Comp | $275M | $370M | $380M | $366M | $754M | $194M | $194M | $193M | $164M | $129M | $133M | $153M | |
| Deferred Tax | $119M | $-117M | $-34M | $-23M | $-76M | $117M | $5M | $-18M | $34M | $7M | $-45M | $-20M | |
| Amort. of Intangibles | $67M | $130M | $197M | $179M | $75M | $31M | $37M | $39M | $46M | $51M | $54M | $51M | |
| Restructuring | $47M | $16M | $52M | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-435M | $1.45B | $861M | $4.06B | $-1.15B | $-74M | $-338M | $-38M | $-205M | $-53M | · | · | |
| Operating Cash Flow | $1.08B | $837M | $478M | $392M | $545M | $1.08B | $1.05B | $1.14B | $875M | $779M | $786M | $501M | |
| CapEx | $148M | $128M | $195M | $286M | $208M | $189M | $209M | $296M | $310M | $260M | $143M | $106M | |
| Investing Cash Flow | $-55M | $-178M | $-231M | $-591M | $-1.07B | $-554M | $745M | $-1.81B | $-214M | $-515M | $-107M | $-407M | |
| Debt Issued | $495M | $1.24B | $0 | $991M | $988M | $0 | $0 | $735M | $5M | $5M | · | $1.13B | |
| Net Debt Issued | $495M | $1.24B | $0 | $991M | $988M | $0 | $0 | $735M | $5M | $5M | · | · | |
| Stock Issued | $44M | $56M | $67M | $63M | $60M | $61M | $59M | $46M | $71M | $47M | $72M | $96M | |
| Stock Repurchased | $742M | $116M | $0 | $0 | $0 | $736M | $324M | $201M | $251M | $249M | $274M | $237M | |
| Net Stock Activity | $-698M | $-60M | $67M | $63M | $60M | $-675M | $-265M | $-155M | $-180M | $-202M | $-202M | · | |
| Financing Cash Flow | $-744M | $-570M | $-1.21B | $1.00B | $-51M | $-766M | $-897M | $594M | $-176M | $-296M | $-545M | $-167M | |
| Net Change in Cash | $291M | $79M | $-963M | $779M | $-578M | $-232M | $898M | $-81M | $490M | $-34M | $133M | $-75M | |
| Taxes Paid | $73M | $105M | $65M | $122M | $233M | $119M | $164M | $99M | $149M | $60M | $17M | $18M | |
| Free Cash Flow | $931M | $709M | $283M | $106M | $337M | $891M | $842M | $846M | $565M | $427M | $517M | · | |
| Levered FCF | · | · | $203M | $80M | $284M | $853M | $796M | $796M | $541M | $402M | $484M | · |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% | 68.0% | 69.6% | 69.0% | 66.3% | 69.5% | 69.8% | · | |
| Operating Margin | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% | 17.9% | 27.8% | 26.5% | 22.0% | 24.5% | 27.6% | · | |
| Net Margin | 19.6% | -28.0% | -25.8% | -96.1% | 16.8% | 20.2% | 28.3% | 24.8% | 26.4% | 19.3% | 20.8% | · | |
| Pretax Margin | 25.0% | -27.0% | -24.8% | -94.6% | 19.5% | 26.4% | 31.6% | 26.8% | 37.9% | 23.4% | 26.3% | · | |
| EBITDA Margin | 24.8% | -11.0% | -14.1% | -82.6% | 2.8% | 23.7% | 33.1% | 31.9% | 27.7% | 30.4% | 27.6% | · | |
| ROA | 13.1% | -14.9% | -10.4% | -32.1% | 6.7% | 8.8% | 14.0% | 13.5% | 15.2% | 11.6% | 13.1% | · | |
| ROE | 34.1% | -54.4% | -19.9% | -66.1% | 7.1% | 14.0% | 22.1% | 25.4% | 29.4% | 22.9% | 27.9% | · | |
| ROIC | 19.6% | -30.1% | -19.3% | -59.8% | -0.99% | 7.6% | 15.2% | 13.4% | 10.0% | 13.8% | 16.4% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.1 | 1.8 | 1.7 | 1.3 | 2.5 | 3.6 | 6.7 | 2.5 | 4.0 | 3.3 | 3.4 | · | |
| Quick Ratio | 0.7 | 0.5 | 0.5 | 0.3 | 0.7 | 1.7 | 2.9 | 2.2 | 3.4 | 2.8 | 2.9 | · | |
| Debt / Equity | 0.2 | 0.2 | 0.0 | 0.1 | · | 0.3 | 0.2 | 0.5 | 0.4 | 0.5 | 0.6 | · | |
| LT Debt / Equity | · | · | · | · | · | 0.1 | 0.2 | 0.2 | 0.4 | 0.5 | 0.5 | · | |
| Interest Coverage | · | · | -13.9 | -160.7 | -2.0 | 11.8 | 18.9 | 15.5 | 16.4 | 17.7 | 14.5 | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.7 | 0.5 | 0.4 | 0.3 | 0.4 | 0.4 | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.7 | 2.7 | 3.0 | 3.2 | 3.4 | 2.8 | 2.9 | 2.9 | 2.9 | 2.6 | 2.9 | · | |
| Receivables Turnover | 5.5 | 6.0 | 6.4 | 7.0 | 8.0 | 6.1 | 6.5 | 7.2 | 6.9 | 6.3 | 6.6 | · |
Wachstumsraten 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.66% | -2.9% | -1.8% | 1.3% | 39.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.8% | -1.1% | 11.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 6.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | 13.3% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | 16.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 5.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B | $3.24B | $3.54B | $3.33B | $2.75B | $2.40B | $2.22B | $1.86B | |
| Net Income TTM | $850M | $-1.22B | $-1.16B | $-4.40B | $762M | $656M | $1.00B | $826M | $726M | $463M | $462M | $353M | |
| Market Cap | $20.65B | $21.51B | $21.54B | $31.08B | $58.10B | $52.55B | $47.52B | $42.65B | $31.24B | $18.21B | $27.37B | · | |
| Enterprise Value | · | · | · | · | · | · | · | $41.13B | $30.29B | $17.70B | $27.07B | · | |
| P/E | 24.8 | -17.6 | -18.5 | -7.0 | 73.4 | 80.9 | 48.0 | 52.2 | 43.2 | 40.6 | 60.2 | 77.2 | |
| P/S | 4.8 | 4.9 | 4.8 | 6.8 | 12.8 | 16.2 | 13.4 | 12.8 | 11.4 | 7.6 | 12.3 | · | |
| P/B | 7.6 | 9.1 | 3.7 | 4.7 | 5.4 | 11.2 | 10.3 | 11.3 | 11.4 | 8.3 | 14.8 | · | |
| P / Tangible Book | 14.7 | 22.3 | 104.0 | 414.4 | 154.1 | 14.4 | · | · | · | · | · | · | |
| P / Cash Flow | 19.1 | 25.7 | 45.1 | 79.3 | 106.6 | 48.7 | 45.2 | 37.3 | 35.7 | 26.5 | 41.5 | · | |
| P / FCF | 22.2 | 30.3 | 76.1 | 293.2 | 172.4 | 59.0 | 56.4 | 50.4 | 55.3 | 42.6 | 53.0 | · | |
| EV / EBITDA | · | · | · | · | · | · | · | 38.7 | 39.8 | 24.3 | 44.2 | · | |
| EV / FCF | · | · | · | · | · | · | · | 48.6 | 53.6 | 41.4 | 52.4 | · | |
| EV / Revenue | · | · | · | · | · | · | · | 12.3 | 11.0 | 7.4 | 12.2 | · | |
| Earnings Yield | 4.0% | -5.7% | -5.4% | -14.2% | 1.4% | 1.2% | 2.1% | 1.9% | 2.3% | 2.5% | 1.7% | 1.3% |
Gewinn- und Verlustrechnung 18
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.16B | $1.09B | $1.16B | $1.08B | $1.06B | $1.04B | $1.10B | $1.08B | $1.11B | $1.08B | $1.02B | $1.18B | $1.09B | $1.11B | |
| Cost of Revenue | $389M | $370M | $400M | $351M | $364M | $358M | $376M | $335M | $391M | $409M | $476M | $444M | $432M | $480M | |
| Gross Profit | $770M | $721M | $759M | $733M | $695M | $683M | $728M | $745M | $721M | $667M | $542M | $732M | $655M | $626M | |
| R&D Expense | $252M | $240M | $239M | $229M | $247M | $252M | $252M | $253M | $325M | $339M | $332M | $358M | $341M | $474M | |
| SG&A Expense | $273M | $272M | $308M | $277M | $234M | $267M | $267M | $239M | $147M | $439M | $464M | $462M | $378M | $205M | |
| Operating Expenses | $525M | $512M | $557M | $506M | $481M | $519M | $554M | $4M | $2.36B | $778M | $1.64B | $820M | $719M | $4.60B | |
| Operating Income | $245M | $209M | $202M | $227M | $214M | $164M | $174M | $741M | $-1.64B | $-111M | $-1.10B | $-88M | $-64M | $-3.98B | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $18M | · | $19M | $20M | · | |
| Interest Income | $8M | $11M | $10M | $9M | $10M | $11M | $10M | $11M | $13M | $12M | $24M | $17M | $17M | $9M | |
| Other Non-op | $31M | $-39M | $192M | $9M | $107M | $32M | $28M | $4M | $-332M | $8M | $19M | $1M | $-11M | $-45M | |
| Pretax Income | $260M | $157M | $378M | $220M | $306M | $182M | $186M | $720M | $-1.98B | $-109M | $-1.09B | $-89M | $-78M | $-4.01B | |
| Income Tax | $53M | $23M | $44M | $70M | $71M | $51M | $0 | $15M | $12M | $17M | $-74M | $145M | $-81M | $94M | |
| Net Income | $207M | $134M | $334M | $150M | $235M | $131M | $186M | $705M | $-1.99B | $-126M | $-791M | $-234M | $3M | $-4.10B | |
| EPS (Basic) | $1.37 | $0.88 | $2.17 | $0.98 | $1.49 | $0.83 | $1.15 | $4.43 | $-12.48 | $-0.79 | $-6.43 | $-1.48 | $0.02 | $-26.16 | |
| EPS (Diluted) | $1.35 | $0.87 | $2.16 | $0.98 | $1.49 | $0.82 | $1.16 | $4.42 | $-12.48 | $-0.79 | $-6.43 | $-1.48 | $0.02 | $-26.15 | |
| Shares (Basic) | 151,000,000 | 153,000,000 | -314,000,000 | 153,000,000 | 157,000,000 | 159,000,000 | -318,000,000 | 159,000,000 | 159,000,000 | 159,000,000 | -315,000,000 | 158,000,000 | 158,000,000 | -303,000,000 | |
| Shares (Diluted) | 153,000,000 | 154,000,000 | -314,000,000 | 154,000,000 | 157,000,000 | 159,000,000 | -319,000,000 | 160,000,000 | 159,000,000 | 159,000,000 | -317,000,000 | 158,000,000 | 158,000,000 | -306,000,000 | |
| EBITDA | $245M | $209M | · | $294M | $282M | $233M | · | $741M | $-1.64B | $-111M | · | $-88M | $-64M | · |
Bilanz 27
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Short-term Investments | $128M | $66M | $215M | $228M | $221M | $124M | $93M | $70M | $74M | · | · | $6M | $24M | · | |
| Receivables | $764M | $738M | $854M | $729M | $701M | $699M | $735M | $699M | $641M | $635M | · | $741M | $665M | · | |
| Inventory | $629M | $611M | $564M | $590M | $575M | $537M | $547M | $574M | $561M | $584M | · | $617M | $586M | · | |
| Prepaid Expense | $273M | $234M | $238M | $199M | $210M | $200M | $244M | $161M | $263M | $256M | · | $306M | $403M | · | |
| Current Assets | $2.83B | $2.74B | $3.29B | $2.80B | $2.64B | $2.67B | $2.75B | $2.37B | $2.46B | $2.58B | · | $3.22B | $3.17B | · | |
| PP&E (Net) | $745M | $755M | $759M | $748M | $764M | $782M | $815M | $832M | $859M | $964M | · | $1.07B | $1.08B | · | |
| PP&E (Gross) | · | · | $2.12B | · | · | · | $2.07B | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1.36B | · | · | · | $1.25B | · | · | · | · | · | · | · | |
| Goodwill | $1.28B | $1.28B | $1.11B | $1.11B | $1.11B | $1.11B | $1.11B | $1.11B | $1.08B | $2.54B | $2.54B | $3.24B | $3.24B | $3.24B | |
| Intangibles | $410M | $430M | $210M | $225M | $238M | $278M | $295M | $305M | $278M | $2.94B | · | $3.19B | $3.24B | · | |
| Other Non-current Assets | $576M | $523M | $449M | $423M | $400M | $373M | $348M | $321M | $314M | $458M | · | $417M | $423M | · | |
| Total Assets | $6.65B | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B | $10.04B | · | $11.77B | $11.81B | · | |
| Accounts Payable | $230M | $218M | $240M | $218M | $200M | $207M | $221M | $191M | $199M | $201M | · | $244M | $242M | · | |
| Accrued Liabilities | $848M | $849M | $846M | $746M | $762M | $734M | $827M | $784M | $1.26B | $1.27B | · | $1.31B | $1.24B | · | |
| Short-term Debt | $500M | $499M | $499M | $998M | $499M | $499M | $499M | · | $744M | · | · | $0 | $0 | · | |
| Current Liabilities | $1.58B | $1.57B | $1.58B | $1.96B | $1.46B | $1.44B | $1.55B | $975M | $2.21B | $1.47B | · | $2.30B | $2.23B | · | |
| Capital Leases | $454M | $475M | $486M | $506M | $528M | $539M | $554M | $613M | $616M | $700M | · | $726M | $747M | · | |
| Other Non-current Liabilities | $289M | $352M | $360M | $334M | $348M | $344M | $339M | $313M | $331M | $642M | · | $702M | $654M | · | |
| Total Debt | $500M | $499M | · | $998M | $499M | $499M | · | · | $744M | · | · | · | · | · | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | · | |
| Paid-in Capital | $7.93B | $7.86B | $7.82B | $7.76B | $7.68B | $7.61B | $7.53B | $7.45B | $7.35B | $9.66B | · | $9.40B | $9.31B | · | |
| Retained Earnings | $-51M | $-258M | $-392M | $-726M | $-876M | $-1.11B | $-1.24B | $-1.43B | $-2.13B | $-145M | · | $911M | $1.15B | · | |
| Treasury Stock | $5.05B | $4.93B | $4.70B | $4.64B | $4.52B | $4.14B | $3.93B | $3.89B | $3.79B | $3.79B | · | $3.77B | $3.76B | · | |
| AOCI | $8M | $1M | $-10M | $-12M | $-21M | $8M | $22M | $-5M | $14M | $12M | · | $12M | $-1M | · | |
| Stockholders' Equity | $2.84B | $2.68B | $2.72B | $2.38B | $2.26B | $2.37B | $2.37B | $2.12B | $1.44B | $5.73B | $5.75B | $6.55B | $6.69B | $6.60B | |
| Liabilities + Equity | $6.65B | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B | $10.04B | · | $11.77B | $11.81B | · | |
| Shares Outstanding | 201,000,000 | 201,000,000 | 153,000,000 | 201,000,000 | 201,000,000 | 201,000,000 | 159,000,000 | 199,000,000 | 199,000,000 | 199,000,000 | 199,000,000 | 198,000,000 | 198,000,000 | 198,000,000 |
Cashflow 17
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $66M | $67M | $68M | $69M | $71M | $70M | $105M | $108M | · | · | · | $232M | |
| Stock-based Comp | $73M | $60M | $63M | $70M | $69M | $73M | $79M | $83M | $112M | $96M | $94M | · | $93M | $100M | |
| Amort. of Intangibles | $19M | $18M | $16M | $17M | $17M | $17M | $17M | $17M | $47M | $49M | $57M | $49M | $50M | $112M | |
| Restructuring | · | · | $6M | $2M | $8M | $31M | $2M | $6M | $4M | $4M | · | $26M | · | · | |
| Other Non-cash | · | · | · | · | · | $-33M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $201M | $289M | $321M | $284M | $234M | $240M | $364M | $316M | $80M | $77M | $224M | · | $10M | $147M | |
| CapEx | $40M | $38M | $55M | $31M | $30M | $32M | $29M | $32M | $31M | $36M | $51M | · | $52M | $88M | |
| Investing Cash Flow | $-122M | $-366M | $108M | $-51M | $-49M | $-63M | $-48M | $-41M | $-41M | $-48M | $-85M | · | $-56M | $-102M | |
| Debt Issued | · | · | $495M | · | · | · | $0 | · | · | · | · | · | · | $3M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | $-500M | · | |
| Stock Issued | $0 | $24M | $0 | $16M | $1M | $27M | $0 | $20M | $0 | $36M | $0 | · | $37M | $0 | |
| Stock Repurchased | $128M | $242M | $42M | $130M | $370M | $200M | $17M | $99M | $0 | $0 | $0 | · | · | $0 | |
| Net Stock Activity | · | $-218M | · | · | · | $-173M | · | · | · | $36M | · | · | $37M | · | |
| Financing Cash Flow | $-129M | $-251M | $-63M | $-115M | $-371M | $-195M | $-47M | $-332M | $-226M | $35M | $-27M | · | $-473M | $956M | |
| Net Change in Cash | $-49M | $-329M | $368M | $116M | $-179M | $-14M | $258M | $-51M | $-188M | $60M | $121M | · | $-517M | $1.01B | |
| Free Cash Flow | · | $251M | · | · | · | $208M | · | · | · | $41M | · | · | $-42M | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $20M | · | · | $-41M | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 66.4% | 66.1% | · | 67.6% | 65.6% | 65.6% | · | 69.0% | 64.8% | 62.0% | · | 62.2% | 60.3% | · | |
| Operating Margin | 21.1% | 19.2% | · | 20.9% | 20.2% | 15.8% | · | 68.6% | -147.2% | -10.3% | · | -7.5% | -5.9% | · | |
| Net Margin | 17.9% | 12.3% | · | 13.8% | 22.2% | 12.6% | · | 65.3% | -178.8% | -11.7% | · | -19.9% | 0.28% | · | |
| Pretax Margin | 22.4% | 14.4% | · | 20.3% | 28.9% | 17.5% | · | 66.7% | -177.7% | -10.1% | · | -7.6% | -7.2% | · | |
| EBITDA Margin | 21.1% | 19.2% | · | 27.1% | 26.6% | 22.4% | · | 68.6% | -147.2% | -10.3% | · | -7.5% | -5.9% | · | |
| ROA | 3.2% | 2.1% | · | 2.5% | 3.9% | 1.6% | · | 8.7% | -22.3% | -1.1% | · | · | · | · | |
| ROE | 8.1% | 5.3% | · | 6.7% | 12.7% | 3.2% | · | 17.6% | -49.8% | -2.0% | · | · | · | · | |
| ROIC | 5.8% | 5.6% | · | 4.6% | 6.0% | 4.1% | · | 34.1% | -75.5% | -2.2% | · | · | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | 1.7 | · | 1.4 | 1.8 | 1.9 | · | 2.4 | 1.1 | 1.8 | · | · | · | · | |
| Quick Ratio | 0.6 | 0.5 | · | 0.5 | 0.6 | 0.6 | · | 0.8 | 0.3 | 0.4 | · | · | · | · | |
| Debt / Equity | 0.2 | 0.2 | · | 0.4 | 0.2 | 0.2 | · | · | 0.5 | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -6.2 | · | -4.6 | -3.2 | · |
Effizienz 3
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | · | · | · | |
| Receivables Turnover | 1.6 | 1.5 | · | 1.5 | 1.6 | 1.6 | · | 1.6 | 1.6 | 1.7 | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2027 | Q1 2027 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.39B | $4.28B | · | $4.26B | $4.29B | $4.31B | · | $4.39B | $4.48B | $4.46B | · | $4.49B | $4.48B | · | |
| Net Income TTM | $825M | $853M | · | $702M | $1.26B | $-966M | · | $-1.58B | $-3.04B | $-1.29B | · | $-4.19B | · | · | |
| Market Cap | $35.49B | $23.65B | · | $18.43B | $19.05B | $16.08B | · | $25.89B | $20.77B | $26.58B | · | · | · | · | |
| P/E | 37.6 | 28.3 | · | 11.9 | -16.5 | -10.0 | · | -9.6 | -5.3 | -19.0 | · | -3.6 | -4.4 | · | |
| P/S | 8.1 | 5.5 | · | 4.3 | 4.4 | 3.7 | · | 5.9 | 4.6 | 6.0 | · | · | · | · | |
| P/B | 12.5 | 8.8 | · | 7.7 | 8.4 | 6.8 | · | 12.2 | 14.5 | 4.6 | · | · | · | · | |
| P / Tangible Book | 31.0 | 24.6 | · | 17.7 | 21.0 | 16.5 | · | 36.6 | 262.9 | 106.8 | · | · | · | · | |
| P / Cash Flow | · | 81.8 | · | · | · | 67.0 | · | · | · | 345.2 | · | · | · | · | |
| P / FCF | · | 94.2 | · | · | · | 77.3 | · | · | · | 648.4 | · | · | · | · | |
| Earnings Yield | 2.7% | 3.5% | · | 8.4% | -6.1% | -10.0% | · | -10.5% | -18.7% | -5.3% | · | -27.4% | -22.9% | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Umsatz | $4.34B | $4.37B | $4.50B | $4.58B | $4.53B |
| Bruttogewinnmarge % | 66.1% | 65.4% | 60.9% | 64.8% | 69.7% |
| Betriebsgewinnmarge % | 18.6% | -19.1% | -23.7% | -91.2% | -2.7% |
| Nettoergebnis | $850M | $-1.22B | $-1.16B | $-4.40B | $762M |
| Verwässerte EPS | $5.45 | $-7.69 | $-7.34 | $-28.00 | $5.04 |
Bilanz
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.2 | 0.2 | 0.0 | 0.1 | — |
| Liquiditätsgrad | 2.1 | 1.8 | 1.7 | 1.3 | 2.5 |
| Quick Ratio | 0.7 | 0.5 | 0.5 | 0.3 | 0.7 |
Cashflow
| 2025-12-28 | 2024-12-29 | 2023-12-31 | 2023-01-01 | 2022-01-02 | |
|---|---|---|---|---|---|
| Freier Cashflow | $931M | $709M | $283M | $106M | $337M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 1.010 Einreicher · $18.4B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 165 (+52 vs. Vorquartal) | 60 (-34 vs. Vorquartal) | 296 (+14 vs. Vorquartal) | 321 (0 vs. Vorquartal) | +12.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Capital World Investors | $2.712.230.480 | 15.425.298 | 14,76% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.165.253.015 | 6.627.157 | 6,34% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.158.286.103 | 6.587.534 | 6,30% | Aktien |
| STATE STREET CORP | $1.144.176.449 | 6.507.288 | 6,23% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $1.124.033.551 | 6.206.701 | 6,12% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $617.980.735 | 3.514.649 | 3,36% | Aktien |
| FMR LLC | $523.532.529 | 2.977.492 | 2,85% | Aktien |
| Corvex Management LP | $497.695.958 | 2.830.552 | 2,71% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $412.561.415 | 2.354.283 | 2,24% | Aktien |
| LOOMIS SAYLES & CO L P | $298.854.639 | 1.699.679 | 1,63% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $284.828.951 | 1.619.911 | 1,55% | Aktien |
| JANUS HENDERSON GROUP PLC | $246.405.738 | 1.999.073 | 1,34% | Aktien |
| Sessa Capital IM, L.P. | $196.643.700 | 1.118.374 | 1,07% | Aktien |
| AMERIPRISE FINANCIAL INC | $191.377.137 | 1.088.353 | 1,04% | Aktien |
| ARK Investment Management LLC | $183.744.158 | 1.045.010 | 1,00% | Aktien |
| Senvest Management, LLC | $177.362.886 | 1.008.718 | 0,97% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $167.266.376 | 951.296 | 0,91% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $167.050.984 | 950.071 | 0,91% | Aktien |
| FIRST TRUST ADVISORS LP | $159.563.763 | 907.489 | 0,87% | Aktien |
| PointState Capital LP | $151.602.384 | 862.210 | 0,82% | Aktien |
| LETKO, BROSSEAU & ASSOCIATES INC | $145.990.418 | 830.293 | 0,79% | Aktien |
| NORGES BANK | $145.424.246 | 827.073 | 0,79% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $145.348.463 | 826.642 | 0,79% | Aktien |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $129.791.552 | 738.165 | 0,71% | Aktien |
| GUARDCAP ASSET MANAGEMENT Ltd | $128.748.557 | 740.132 | 0,70% | Aktien |
| Chevy Chase Trust Holdings, LLC | $127.952.370 | 727.705 | 0,70% | Aktien |
| Quantinno Capital Management LP | $117.941.015 | 670.767 | 0,64% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $111.675.435 | 635.133 | 0,61% | Aktien |
| Amova Asset Management Americas, Inc. | $108.658.017 | 617.972 | 0,59% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $108.597.114 | 881.041 | 0,59% | Aktien |
| Alyeska Investment Group, L.P. | $102.285.586 | 581.730 | 0,56% | Aktien |
| RHUMBLINE ADVISERS | $98.590.641 | 560.716 | 0,54% | Aktien |
| BROWN ADVISORY INC | $96.835.682 | 550.735 | 0,53% | Aktien |
| Stephens Investment Management Group LLC | $94.583.529 | 537.926 | 0,51% | Aktien |
| Casdin Capital, LLC | $93.189.900 | 530.000 | 0,51% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $90.531.934 | 515.499 | 0,49% | Aktien |
| Caisse de depot et placement du Quebec | $86.532.800 | 492.139 | 0,47% | Aktien |
| GOLDMAN SACHS GROUP INC | $84.217.839 | 478.973 | 0,46% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $82.394.290 | 468.602 | 0,45% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $82.176.517 | 467.365 | 0,45% | Aktien |
| Spyglass Capital Management LLC | $80.665.002 | 458.767 | 0,44% | Aktien |
| BlackRock, Inc. | $77.542.612 | 441.009 | 0,42% | Aktien |
| Swiss National Bank | $73.918.932 | 420.400 | 0,40% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $72.810.204 | 414.094 | 0,40% | Aktien |
| M&G PLC | $71.140.608 | 404.208 | 0,39% | Aktien |
| Southpoint Capital Advisors LP | $70.332.000 | 400.000 | 0,38% | Aktien |
| National Pension Service | $65.031.780 | 369.856 | 0,35% | Aktien |
| KEYBANK NATIONAL ASSOCIATION/OH | $64.398.474 | 366.254 | 0,35% | Aktien |
| LMR Partners LLP | $62.631.877 | 356.207 | 0,34% | Aktien |
| Gotham Asset Management, LLC | $62.627.657 | 356.183 | 0,34% | Aktien |
| Patient Capital Management, LLC | $60.716.695 | 345.314 | 0,33% | Aktien |
| BANK OF AMERICA CORP /DE/ | $59.969.108 | 341.063 | 0,33% | Aktien |
| California Public Employees Retirement System | $59.582.457 | 338.864 | 0,32% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $58.761.155 | 334.193 | 0,32% | Aktien |
| BAILLIE GIFFORD & CO | $57.855.807 | 329.044 | 0,31% | Aktien |
| Douglas Lane & Associates, LLC | $57.088.338 | 324.679 | 0,31% | Aktien |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | $55.453.265 | 315.380 | 0,30% | Aktien |
| Robeco Institutional Asset Management B.V. | $54.117.836 | 307.785 | 0,29% | Aktien |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $53.037.713 | 301.642 | 0,29% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $51.879.696 | 295.056 | 0,28% | Aktien |
| Ilex Capital Partners (UK) LLP | $50.837.904 | 289.131 | 0,28% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $49.655.000 | 282.402 | 0,27% | Aktien |
| Pictet Asset Management Holding SA | $48.335.824 | 268.581 | 0,26% | Aktien |
| TEACHER RETIREMENT SYSTEM OF TEXAS | $48.163.179 | 273.919 | 0,26% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $47.981.443 | 272.885 | 0,26% | Aktien |
| IEQ CAPITAL, LLC | $47.110.622 | 267.932 | 0,26% | Aktien |
| JENNISON ASSOCIATES LLC | $46.171.981 | 262.594 | 0,25% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $45.645.123 | 348.011 | 0,25% | Aktien |
| ROYAL BANK OF CANADA | $43.456.000 | 247.148 | 0,24% | Aktien |
| ASR Vermogensbeheer N.V. | $43.316.775 | 246.356 | 0,24% | Aktien |
| AustralianSuper Pty Ltd | $41.627.928 | 236.751 | 0,23% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $41.306.863 | 234.925 | 0,22% | Aktien |
| BAMCO INC /NY/ | $39.929.938 | 227.094 | 0,22% | Aktien |
| Legal & General Group Plc | $39.368.159 | 223.899 | 0,21% | Aktien |
| Cannell & Spears LLC | $36.928.050 | 210.021 | 0,20% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $33.545.023 | 190.781 | 0,18% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $33.236.344 | 189.272 | 0,18% | Aktien |
| NORTH STAR ASSET MANAGEMENT INC | $33.038.984 | 187.903 | 0,18% | Aktien |
| Eagle Health Investments LP | $32.952.828 | 187.413 | 0,18% | Aktien |
| VANGUARD GROUP INC | $32.906.339 | 250.887 | 0,18% | Aktien |
| MORGAN STANLEY | $32.416.825 | 184.364 | 0,18% | Aktien |
| Baird Financial Group, Inc. | $31.122.437 | 177.003 | 0,17% | Aktien |
| BARCLAYS PLC | $31.054.392 | 176.616 | 0,17% | Aktien |
| Howard Capital Management, LLC | $31.000.587 | 176.310 | 0,17% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $30.910.914 | 175.800 | 0,17% | Kaufoption |
| Mitsubishi UFJ Asset Management Co., Ltd. | $30.501.230 | 173.470 | 0,17% | Aktien |
| PFA Pension, Forsikringsaktieselskab | $30.069.940 | 171.017 | 0,16% | Aktien |
| OSTRUM ASSET MANAGEMENT | $29.637.026 | 168.555 | 0,16% | Aktien |
| Artisan Partners Limited Partnership | $29.485.109 | 167.691 | 0,16% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $29.159.125 | 236.566 | 0,16% | Aktien |
| Mitsubishi UFJ Trust & Banking Corp | $29.130.459 | 165.674 | 0,16% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $28.451.052 | 161.810 | 0,15% | Aktien |
| CIBC Private Wealth Group LLC | $28.430.314 | 299.361 | 0,15% | Aktien |
| Hardman Johnston Global Advisors LLC | $28.131.745 | 159.994 | 0,15% | Aktien |
| Retirement Systems of Alabama | $27.515.109 | 156.487 | 0,15% | Aktien |
| PEAK6 LLC | $25.653.597 | 145.900 | 0,14% | Kaufoption |
| Assenagon Asset Management S.A. | $24.616.727 | 140.003 | 0,13% | Aktien |
| Candriam S.C.A. | $24.288.272 | 138.268 | 0,13% | Aktien |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $24.059.346 | 136.833 | 0,13% | Aktien |
| NORTH STAR ASSET MANAGEMENT INC | $23.514.310 | 190.770 | 0,13% | Aktien |
Unternehmensinsider 88 Insider · 50 Führungskräfte · 29 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jacob Thaysen | Chief Executive Officer | 5. März 2026 A | 109.073 | 0 | 0 | $0 |
| Francis A Desouza | President and CEO | 1. März 2023 A | 120.992 | 0 | 0 | $0 |
| Ankur Dhingra | SVP, Chief Financial Officer | 5. März 2026 A | 34.264 | 0 | 0 | $0 |
| Joydeep Goswami | SVP, Chief Financial Officer | 5. März 2024 A | 24.478 | 0 | 0 | $0 |
| Sam Samad | SVP and CFO | 1. März 2022 A | 11.297 | 0 | 0 | $0 |
| Timothy M Kish | VP Finance & CFO | 2. März 2005 A | — | 0 | 0 | $0 |
| John R Stuelpnagel | Sr VP and COO | 27. März 2008 M | 337.836 | 0 | 0 | $0 |
| Scott M Davies | Chief Legal Officer | 30. Juli 2026 S | 20.338 | 0 | 5 | $-531.273 |
| Patricia Leckman | SVP, Chief People Officer | 5. Juni 2026 S | 21.259 | 0 | 9 | $-529.720 |
| Scott D Ericksen | VP, Chief Accounting Officer | 29. Mai 2026 S | 14.446 | 0 | 2 | $-305.150 |
| Christensen Jakob Wedel | SVP, Strategy/Corp Development | 6. Mai 2026 S | 15.056 | 0 | 2 | $-168.297 |
| Steven Barnard | SVP, Chief Technology Officer | 5. März 2026 A | 41.335 | 0 | 0 | $0 |
| Kevin Carl Pegels | Chief of Global Operations | 5. März 2026 A | 29.038 | 0 | 0 | $0 |
| Everett Cunningham | SVP, Chief Commercial Officer | 5. Juli 2025 F | 41.942 | 0 | 0 | $0 |
| Carissa Rollins | SVP, Chief Information Officer | 5. April 2025 F | 18.447 | 0 | 0 | $0 |
| Charles Dadswell | SVP, General Counsel | 13. September 2024 D | 20.586 | 0 | 0 | $0 |
| Kathryne Gambrell Reeves | SVP, Chief Marketing Officer | 5. März 2024 A | 17.965 | 0 | 0 | $0 |
| Aimee L Hoyt | SVP, Chief People Officer | 7. November 2023 S | 8.314 | 0 | 0 | $0 |
| Susan H Tousi | SVP, Chief Commercial Officer | 5. November 2023 F | 43.743 | 0 | 0 | $0 |
| Alexander Aravanis | SVP, Chief Technology Officer | 5. Juli 2023 F | 12.587 | 0 | 0 | $0 |
| John Edward Frank | Chief Public Affairs Officer | 5. Mai 2023 F | 9.166 | 0 | 0 | $0 |
| Phillip G. Febbo | SVP Chief Medical Officer | 1. März 2023 A | 14.786 | 0 | 0 | $0 |
| Jose Torres | VP, Chief Accounting Officer | 5. Mai 2022 F | 1.748 | 0 | 0 | $0 |
| Karen K Mcginnis | VP, Chief Accounting Officer | 18. Februar 2021 S | 1.538 | 0 | 0 | $0 |
| Robert P Ragusa | SVP, Global Quality & Ops | 17. Februar 2021 M | 9.617 | 0 | 0 | $0 |
| Mostafa Ronaghi | SVP, Entrepreneurial Devlopmt | 10. Dezember 2020 S | 80.162 | 0 | 0 | $0 |
| Mark Van Oene | SVP Chief Commercial Officer | 5. November 2020 F | 16.575 | 0 | 0 | $0 |
| Omead Ostadan | SVP Mktg, Prod & Strat Plan | 11. Mai 2020 S | 17.172 | 0 | 0 | $0 |
| Malcolm Garret Hampton | SVP Clinical Genomics Group | 9. Januar 2020 F | 6.598 | 0 | 0 | $0 |
| Marc Stapley | EVP Strategy & Corp Developmt | 6. Dezember 2018 S | 6.957 | 0 | 0 | $0 |
| Michel Bouchard | Chief Accounting Officer | 6. November 2017 F | 9.538 | 0 | 0 | $0 |
| Christian O Henry | EVP & Chief Commercial Officer | 30. Januar 2017 F | 17.531 | 0 | 0 | $0 |
| Tristan Orpin | EVP Clinical Genomics | 7. November 2016 F | 118.259 | 0 | 0 | $0 |
| Nicholas Naclerio | Sr VP, Corporate Development | 21. März 2016 S | 30.020 | 0 | 0 | $0 |
| Richard Klausner | Sr VP, Chief Medical Officer | 29. Januar 2016 F | 22.847 | 0 | 0 | $0 |
| Gregory Heath | Sr VP & General Manager | 17. Dezember 2013 M | 26.740 | 0 | 0 | $0 |
| Mark L Lewis | Sr VP & General Manager | 1. November 2013 M | 44.837 | 0 | 0 | $0 |
| Matthew L. Posard | Sr VP & General Manager | 30. Mai 2013 M | 30.858 | 0 | 0 | $0 |
| Christian Cabou | Sr VP & General Counsel | 23. April 2013 M | 45.553 | 0 | 0 | $0 |
| Joel Mccomb | Sr VP & General Manager | 28. Januar 2010 F | 6.595 | 0 | 0 | $0 |
| John West | Sr. VP & GM DNA Sequencing | 8. November 2007 M | 82.062 | 0 | 0 | $0 |
| Arthur Holden | Sr VP Corp & Market Dev | 25. Januar 2007 A | — | 0 | 0 | $0 |
| David L Barker | Chief Scientific Officer | 29. November 2005 S | 137.636 | 0 | 0 | $0 |
| Alan Kersey | V.P. & Site Manager | 31. August 2005 S | 48.582 | 0 | 0 | $0 |
| Robert C Kain | Vice President Engineering | 23. August 2005 S | 125.311 | 0 | 0 | $0 |
| Kirk Malloy | V.P. of Customer Solutions | 9. Mai 2005 A | — | 0 | 0 | $0 |
| David C Douglas | Vice President Manufacturing | 2. Mai 2005 S | 0 | 0 | 0 | $0 |
| Scott D Kahn | Chief Information Officer | 6. April 2005 A | — | 0 | 0 | $0 |
| Arnold R Oliphant | VP Scientific Operations | 28. Februar 2005 M | 0 | 0 | 0 | $0 |
| Noemi C Espinosa | VP Intellectual Property | 25. Februar 2005 A | 204.704 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Illumina, Inc. ×2 Einreichungen | 5. Februar 2007 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 160 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| GNOM · Global X Funds | 4,82% | 16.512 NS | 31. Mai 2026 | N-PORT |
| ARKG · ARK ETF Trust | 4,03% | 392.835 NS | 30. April 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 3,74% | 1.118.887 SH | 8. August 2026 | Täglich |
| PBE · Invesco Exchange-Traded Fund Trust | 3,10% | 59.706 SH | 8. August 2026 | Täglich |
| AGIQ · Tidal Trust I | 2,49% | 1.730 NS | 31. Mai 2026 | N-PORT |
| IBB · iShares Trust | 2,25% | 1.108.116 SH | 8. August 2026 | Täglich |
| ABOT · Abacus FCF ETF Trust | 2,09% | 727 NS | 30. April 2026 | N-PORT |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1,95% | 8.210 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 1,94% | 8.235 SH | 8. August 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 1,83% | 24.099 SH | 8. August 2026 | Täglich |
| MTRA · Invesco Actively Managed Exchange-T… | 1,46% | 11.131 SH | 8. August 2026 | Täglich |
| THNQ · EXCHANGE TRADED CONCEPTS TRUST | 1,45% | 37.005 NS | 30. April 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 1,37% | 86.304 SH | 8. August 2026 | Täglich |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1,35% | 188.077 NS | 30. April 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,34% | 92.110 NS | 30. April 2026 | N-PORT |
| BIB · ProShares Trust | 1,25% | 5.653 NS | 31. Mai 2026 | N-PORT |
| CVAR · ETF Opportunities Trust | 1,21% | 3.691 NS | 30. April 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 1,20% | 2.373 NS | 31. Mai 2026 | N-PORT |
| ARKK · ARK ETF Trust | 1,20% | 614.284 NS | 30. April 2026 | N-PORT |
| FLCV · Federated Hermes ETF Trust | 1,14% | 6.746 NS | 31. Mai 2026 | N-PORT |
| ANEW · ProShares Trust | 1,06% | 502 NS | 31. Mai 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 1,01% | 1.224 NS | 30. April 2026 | N-PORT |
| MIDE · DBX ETF Trust | 1,01% | 207 NS | 29. Mai 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,99% | 169.737 NS | 31. Mai 2026 | N-PORT |
| XJH · iShares Trust | 0,92% | 20.448 SH | 8. August 2026 | Täglich |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,87% | 20.389 SH | 8. August 2026 | Täglich |
| IJK · iShares Trust | 0,85% | 478.050 SH | 8. August 2026 | Täglich |
| IJH · iShares Trust | 0,81% | 5.220.464 SH | 8. August 2026 | Täglich |
| JOET · Virtus ETF Trust II | 0,78% | 14.553 NS | 30. April 2026 | N-PORT |
| IJJ · iShares Trust | 0,77% | 354.472 SH | 8. August 2026 | Täglich |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,75% | 80.617 SH | 8. August 2026 | Täglich |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,73% | 244.355 SH | 8. August 2026 | Täglich |
| FLCC · Federated Hermes ETF Trust | 0,70% | 5.235 NS | 31. Mai 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,70% | 59.759 SH | 8. August 2026 | Täglich |
| ITAN · EA Series Trust | 0,60% | 3.264 NS | 29. Mai 2026 | N-PORT |
| PJFM · PGIM ETF Trust | 0,59% | 600 NS | 29. Mai 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,57% | 17.611 NS | 30. April 2026 | N-PORT |
| MVV · ProShares Trust | 0,54% | 5.283 NS | 31. Mai 2026 | N-PORT |
| IYH · iShares Trust | 0,48% | 91.002 SH | 8. August 2026 | Täglich |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 47.842 NS | 30. April 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,47% | 12.715 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,39% | 448.145 SH | 8. August 2026 | Täglich |
| MIDU · Direxion Shares ETF Trust | 0,38% | 2.532 NS | 30. April 2026 | N-PORT |
| FLCG · Federated Hermes ETF Trust | 0,38% | 13.255 NS | 31. Mai 2026 | N-PORT |
| UMDD · ProShares Trust | 0,38% | 738 NS | 31. Mai 2026 | N-PORT |
| SMIZ · Zacks Trust | 0,35% | 5.614 NS | 31. Mai 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,35% | 951.944 SH | 8. August 2026 | Täglich |
| BFOR · ALPS ETF Trust | 0,31% | 4.141 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,31% | 70.313 NS | 30. April 2026 | N-PORT |
| COWZ · Pacer Funds Trust | 0,31% | 444.011 NS | 30. April 2026 | N-PORT |